Company intelligence / Profile preview

Revenio Group

Vantaa, Uusimaa, Finlandreveniogroup.fi ↗

Ownership: Private
Development stage: Commercial

Overview

Revenio’s ophthalmic diagnostic solutions are commercialized globally under the iCare brand. Their devices are widely used for intraocular pressure measurement, fundus imaging, perimetry, and clinical software to support diagnosis of major eye diseases such as glaucoma, diabetic retinopathy, and AMD. The company’s products are trusted by physicians worldwide for their reliability and ease of use.[1][4]

Therapeutic areas: PulmonologyOncologyOphthalmology
Modalities: Device (ophthalmic diagnostic devices and software)
Industry: Medical Imaging

Beyond the preview

Go deeper on Revenio Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Revenio Group.

Explore the full profile